Skip to main content
Medical information Clinical review pending

Immunology Testing

Inhibin B Test

The Inhibin B Test measures levels of the hormone inhibin B, produced by the ovaries. It helps assess ovarian function, monitor certain cancers, and guide fertility treatments. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (1 mL minimum) serum from 1 Serum Separator Tube (SST).
Results
Report available on the same day if the sample is received by Monday 9 am. Confirm with the laboratory before booking.
Preparation
For females, preferred sampling time is Day 2 or Day 3 of the menstrual cycle. Please specify the day of your menstrual cycle when booking.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Inhibin B Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Irregular menstrual cycles
  • ✓Fertility assessment
  • ✓Monitoring ovarian reserve
  • ✓Suspected ovarian tumors
  • ✓Evaluation of hormonal imbalances
  • ✓Family history of ovarian cancer
02

In plain language

What this test helps you understand

Assesses ovarian function and reserve. Aids in the diagnosis and monitoring of certain reproductive cancers. Helps evaluate hormonal imbalances related to fertility.
The Inhibin B Test is a specialized diagnostic test that measures the concentration of inhibin B, a hormone produced by the granulosa cells of the ovaries. This hormone plays a critical role in regulating the menstrual cycle and is essential for reproductive health. The test is particularly important for women undergoing fertility assessments and for monitoring certain cancers, especially those affecting the reproductive organs.

The Inhibin B Test specifically detects the levels of inhibin B in the serum. Elevated or decreased levels of this hormone can indicate various health conditions, including ovarian tumors, polycystic ovary syndrome (PCOS), and other disorders of the endocrine system.

Taking the Inhibin B Test provides numerous benefits, including helping assess ovarian function and health, assisting in the diagnosis and monitoring of certain cancers, guiding treatment decisions for fertility-related issues, and offering insights into endocrine disorders.

Results from the Inhibin B Test can vary based on individual health conditions and menstrual cycle timing. Generally, elevated levels may suggest the presence of ovarian tumors or other reproductive issues, while low levels may indicate decreased ovarian reserve. It is essential to consult with your healthcare provider to interpret your results accurately.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationFor females, preferred sampling time is Day 2 or Day 3 of the menstrual cycle. Please specify the day of your menstrual cycle when booking.
Sample2 mL (1 mL minimum) serum from 1 Serum Separator Tube (SST).
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results can be influenced by the menstrual cycle phase. Interpretation requires clinical correlation. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Inhibin B is a hormone produced by the ovaries that plays a role in regulating the menstrual cycle and reproductive function.
This test helps assess ovarian function, evaluate fertility, and monitor certain types of reproductive cancers.
For females, the test is typically done on Day 2 or Day 3 of the menstrual cycle.
Abnormal levels can indicate issues with ovarian function or the presence of certain conditions. Your doctor will interpret the results in the context of your health history.
Yes, for females, it's best to have the test done early in the menstrual cycle (Day 2 or 3). Inform the lab of your cycle day when booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp